DCAL

Dishman Carbogen Amcis Ltd operates in the pharmaceutical and specialty chemicals industries, providing contract research and manufacturing services as well as specialized pharmaceutical development and manufacturing. The company's business segments include Contract Research and Manufacturing Services (CRAMS) and Contract Development and Manufacturing Organization (CDMO). Its offerings encompass specialty chemicals, vitamins and chemicals, disinfectants, early-phase process research and development, late-stage clinical and commercial manufacturing, High Potent Active Pharmaceutical Ingredients (HiPo APIs), and Vitamin D analogues. With over 40 years of experience, Dishman Carbogen Amcis specializes in complex and challenging substances and maintains high-capacity manufacturing and research facilities. The company has a presence across multiple continents, including Switzerland, the UK, Europe, China, and other countries. No information on founders, key management, incorporation details, subsidiaries, or stock listings is provided.